The Weekly Bull Report – April 12, 2020 ?- Coronavirus Curves and Outcomes

Welcome to the 99th edition of The Weekly Bull Report.

This past week we started to see many areas around the world showing progress in flattening the coronavirus curve. This coming week we will see much more and the week after even more. We are getting there. Keep the faith and resilience! ??

“We can complain because rose bushes have thorns, or rejoice because thorns have roses.” – Alphonse Karr ?

Here’s a short list of content we found interesting and informative over the past week…


? Interesting Articles & News:










We recommend The Palm Group:

The Palm Group are experts in Palm Beach real estate and can help find your dream home in the sun. See more here. ??


? Noteworthy Stocks & Assets:

  •  Markets Last Week
    U.S. Indices
    Dow +12.7% to 23,719. S&P 500 +12.1% to 2,790. Nasdaq +10.6% to 8,154. Russell 2000 +18.1% to 1,242. CBOE Volatility Index -11.% to 41.67.S&P 500 Sectors
    Consumer Staples +4.1%. Utilities +12.3%. Financials +13.2%. Telecom +9.2%. Healthcare +8.8%. Industrials +10.7%. Information Technology +10.6%. Materials +15.7%. Energy +14.5%. Consumer Discretionary +12.2%.World Indices
    London +7.9% to 5,843. France +8.5% to 4,507. Germany +10.9% to 10,565. Japan +8.6% to 19,346. China +2.2% to 2,826. Hong Kong +4.6% to 24,300. India +12.9% to 31,160.Commodities and Bonds
    Crude Oil WTI -18.1% to $23.16/bbl. Gold +5.7% to $1,735.1/oz. Natural Gas +7.8% to 1.743. Ten-Year Treasury Yield -0.7% to 138.1.Forex and Cryptos
    EUR/USD +1.13%. USD/JPY +0.04%. GBP/USD +1.57%. Bitcoin +8.1%. Litecoin +13.6%. Ethereum +20.1%. Ripple +10.2%.
  • COVID-19 vaccines and treatments: As clinical trials related to COVID-19 continue to ramp up, the focus next week will start to shift on which vaccines and treatments have the best chance to make it to mass production. There has been a lot of discussion about Gilead Sciences’ (NASDAQ:GILD) remdesivir, Regeneron Pharmaceuticals’ (NASDAQ:REGN) cocktail antibodies and Moderna’s (NASDAQ:MRNA) vaccine candidate. Other companies racing ahead with vaccine trials at various stages include BioNTech (NASDAQ:BNTX), Pfizer (NYSE:PFE), Dynavax Technologies (NASDAQ:DVAX), Vaxart (NASDAQ:VXRT), GlaxoSmithKline (NYSE:GSK), Heat Biologics (NASDAQ:HTBX), Inovio Pharmaceuticals (NASDAQ:INO), Translate Bio (NASDAQ:TBIO), Johnson & Johnson, Arcturus Therapeutics (NASDAQ:ARCT), CSL Behring and Novavax (NASDAQ:NVAX). Treatment candidates are being worked on by privately-held CalciMedica, Amgen (NASDAQ:AMGN), Adaptive Biotechnologies (NASDAQ:ADPT), Takeda Pharmaceutical (NYSE:TAK), CytoDyn (OTCQB:CYDY), Roche Holdings (OTCQX:RHHBY), Regeneron Pharmaceuticals, Tiziana Life Sciences (NASDAQ:TLSA), Vir Biotechnology (NASDAQ:VIR), Eli Lilly (NYSE:LLY), Sanofi (NASDAQ:SNY).


? Stocks On Our Radar:

Our 3 Latest Articles


? Quotes That Inspire Us:

  • “There is only one thing that makes a dream impossible to achieve: the fear of failure.” – Paulo Coelho


? Word Of The Week:

  • Atypical adj. Not conforming to type; unusual or irregular. Deviating from what is usual or common or to be expected; often somewhat odd or strange. “The strong sales were atypical of the normally weak market.”


 Did You Know: 

  • From number 0 to 1000, the letter ‘A’ only appears in 1000 – ‘One thousand’


? A Must Watch & Listen:


? Books We Are Reading:

Our favorite picks for the

  1. Coffeeland: One Man’s Dark Empire and the Making of Our Favorite Drug by Augustine Sedgewick
  2. The Alchemy of Us: How Humans and Matter Transformed One Another by Ainissa Ramirez
  3. The Last Voyage of the Andrea Doria: The Sinking of the World’s Most Glamorous Ship by Greg King and Penny Wilson
  4. Square Haunting: Five Writers in London Between the Wars by Francesca Wade
  5. Hidden Valley Road: Inside the Mind of an American Family by Robert Kolker


? One Liners:

  • What’s the best thing about Switzerland?

  • I don’t know, but the flag is a big plus. ??


? Upcoming Events:

  • Jeff Robinson, CEO of Wuhan/MJ Medtech, is making himself available at 11 and 11:30 am EST this upcoming week: April 13, 15 and 17. To book your 30 minute video call, please send Jeff an email :


Our very best wishes for a brilliant upcoming week! ?

Respectfully yours,

The IBR Team

Please send any news, comments or stock ideas to: and follow IBR on Twitter @IBullReport Resultado de imagen de twitter logo


Luka Marjanovic


Luka holds a Bachelor’s in International Business and a Master’s in International Management. During his undergraduate studies he worked as a research assistant in the field of Big Data; founded his own consulting firm providing services to local SME's in various sectors and invested in the capital markets; as well as working pro-bono providing education and career counselling. Prior to his business education, he studied Biology-and-Biotechnology, and served in the Danish Royal Army as Second Sergeant, leading and managing a group under extreme conditions and pressure. Luka has spent significant time abroad, living and working in seven different countries. When he's not in the office, he's chasing the next gusts windsurfing, carving the mountain snowboarding or out in the forest for a jog.